日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer

PANTAX:一项针对不可切除或转移性胰腺癌的Ib期临床试验,研究外排泵抑制剂SCO-101联合吉西他滨和白蛋白紫杉醇的疗效。

Shim, Susy; Reinacher-Schick, Anke; Kraeft, Anna-Lena; Per Pfeiffer; Tarpgaard, Line Schmidt; Ettrich, Thomas Jens; Kestler, Angelika; Christensen, Signe; Jandu, Haatisha; Nawabi, Mubeen; Roest, Nicklas Lindland; Damstrup, Lars; Vestlev, Peter Michael; Brünner, Nils; Stenvang, Jan; Ladekarl, Morten

Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy

使用 EUS 引导下细针活检对 103 例不可切除的胰腺导管腺癌进行突变分析

Julie Buchberg, Karin de Stricker, Per Pfeiffer, Michael Bau Mortensen, Sönke Detlefsen

Implementing biofeedback treatment in a psychosomatic-psychotherapeutic inpatient unit: a mixed methods evaluation of acceptance, satisfaction, and feasibility

在身心心理治疗住院病房实施生物反馈治疗:接受度、满意度和可行性的混合方法评估

Schmidt, Kira; Barac-Dammeyer, Drazena; Kowalski, Axel; Teigelack, Per; Pfeiffer, Corinna; Robitzsch, Anita; Dörrie, Nora; Skoda, Eva-Maria; Bäuerle, Alexander; Fink, Madeleine; Teufel, Martin

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

治疗前全身炎症循环生物标志物 (CRP、dNLR、YKL-40 和 IL-6) 对接受姑息化疗的转移性结直肠癌脆弱老年患者的预后价值 - 随机 NORDIC9 研究

Gabor Liposits, Halla Skuladottir, Jesper Ryg, Stine Brændegaard Winther, Sören Möller, Eva Hofsli, Carl-Henrik Shah, Laurids Østergaard Poulsen, Åke Berglund, Camilla Qvortrup, Pia Osterlund, Julia S Johansen, Bengt Glimelius, Halfdan Sorbye, Per Pfeiffer

Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

微卫星不稳定性和 BRAF 突变肿瘤高发病率的后果:基于人群的转移性结直肠癌患者队列

Kristine Ø Aasebø, Anca Dragomir, Magnus Sundström, Artur Mezheyeuski, Per-Henrik Edqvist, Geir Egil Eide, Fredrik Ponten, Per Pfeiffer, Bengt Glimelius, Halfdan Sorbye

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

癌胚抗原和碳水化合物抗原 19-9 在转移性结直肠癌中的预后作用:具有高 CA 19-9 水平和不良预后的 BRAF 突变亚群

Maria Thomsen, Eva Skovlund, Halfdan Sorbye, Nils Bolstad, Kjell Johannes Nustad, Bengt Glimelius, Per Pfeiffer, Elin H Kure, Julia S Johansen, Kjell Magne Tveit, Thoralf Christoffersen, Tormod Kyrre Guren4

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

结肠直肠癌成纤维细胞中 claudin-2 表达与治疗相关生存的相关性

Artur Mezheyeuski, Carina Strell, Ina Hrynchyk, Tormod Kyrre Guren, Anca Dragomir, Tatyana Doroshenko, Oksana Pashkova, Julia Gorgun, Kseniya Ruksha, Per Pfeiffer, Elin H Kure, Halfdan Sorbye, David Edler, Anna Martling, Bengt Glimelius, Arne Östman, Anna Portyanko

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

转移性结直肠癌患者的健康相关生活质量与全身炎症反应以及 RAS 和 BRAF 突变状态的关系

Maria Thomsen, Marianne Grønlie Guren, Eva Skovlund, Bengt Glimelius, Marianne Jensen Hjermstad, Julia S Johansen, Elin Kure, Halfdan Sorbye, Per Pfeiffer, Thoralf Christoffersen, Tormod Kyrre Guren, Kjell Magne Tveit

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells

miR-625-3p 通过靶向 MAP2K6-p38 信号传导来调节人类结直肠腺癌细胞中的奥沙利铂耐药性

Mads Heilskov Rasmussen, Iben Lyskjær, Rosa Rakownikow Jersie-Christensen, Line Schmidt Tarpgaard, Bjarke Primdal-Bengtson, Morten Muhlig Nielsen, Jakob Skou Pedersen, Tine Plato Hansen, Flemming Hansen, Jesper Velgaard Olsen, Per Pfeiffer, Torben Falck Ørntoft, Claus Lindbjerg Andersen

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer

TIMP-1 受 EGF 信号轴的调控,促进 KRAS 突变结直肠癌细胞的侵袭性表型:一种治疗转移性结直肠癌的潜在新方法

Line S Tarpgaard, Maj Sofie Ørum-Madsen, Ib J Christensen, Cathrine Nordgaard, Julie Noer, Tormod K Guren, Bengt Glimelius, Halfdan Sorbye, Tone Ikdahl, Elin H Kure, Kjell M Tveit, Hans J Nielsen, Per Pfeiffer, Nils Brünner, José M A Moreira